Keytruda Drug Interactions



Merck Sharp & Dohme


Merck Sharp & Dohme
Full Prescribing Info
Drug Interactions
No formal pharmacokinetic drug interaction studies have been conducted with Pembrolizumab (KEYTRUDA). Since pembrolizumab is cleared from the circulation through catabolism, no metabolic drug-drug interactions are expected.
The use of systemic corticosteroids or immunosuppressants before starting Pembrolizumab (KEYTRUDA) should be avoided because of their potential interference with the pharmacodynamic activity and efficacy of Pembrolizumab (KEYTRUDA). However, systemic corticosteroids or other immunosuppressants can be used after starting Pembrolizumab (KEYTRUDA) to treat immune-mediated adverse reactions. (See Precautions.)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in